Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4

Citation:
Zekri, A. R. N., H. A. Haleem, G. E. - D. Esmat, A. A. Bahnassy, H. M. A. El-Din, M. M. Hafez, A. F. Sharaby, H. Sharaf, and M. S. E. - D. Zakaria. "Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4." JOURNAL OF VIRAL HEPATITIS 14 (2007): 468-477.

Abstract:

n/a

Notes:

n/a